Previous 10 | Next 10 |
home / stock / rammf / rammf news
TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , a leader in plant-derived cannabinoid pharmaceutical products, is pleased to provide an update on their European operations ...
TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp., including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , a leader in plant-derived cannabinoid pharmaceutical products, applauds France’s new regulatory framework for the sal...
TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , a leader in plant-derived cannabinoid pharmaceutical products, welcomes the announcement by Germany’s recently formed...
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or “ RAMM ”) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, announces that Mr. Se...
TORONTO, July 06, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , announces its intention to commence a normal course issuer bid (the “ NCIB ”), under which it may purchase...
TORONTO, June 15, 2021 (GLOBE NEWSWIRE) -- Further to its news releases dated May 12 and June 14, 2021, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM ") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other ...
TORONTO, June 14, 2021 (GLOBE NEWSWIRE) -- Further to its news release dated May 12, 2021, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM ") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-base...
RAMM Pharma ([[RAMMF]]) has entered into a definitive agreement to purchase 100% of European cannabis company Canapar for a total purchase price of about $26.2M.The deal is to purchase all shares of Canapar that RAMM does not currently own in exchange for about 21.9M RAMM shares at a deemed v...
TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM ") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Compa...
TORONTO, April 20, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) (OTC: RAMMF) , a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that the Uruguayan Minis...
News, Short Squeeze, Breakout and More Instantly...
Not for Dissemination in the US or through US Newswire Services TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , is providing an update on its dispute with Sergio Martines an...
TORONTO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the “...
TORONTO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the ȁ...